HAL vs SLRX · P/E 9.3, $19.05B cap vs $4.9M cap
Halliburton Company (HAL) versus Salarius Pharmaceuticals Inc (SLRX) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Salarius Pharmaceuticals Inc (SLRX) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported SLRX revenue for 2023-03-31 was $0. Net income was -$5.3M. SLRX currently screens at market cap $4.9M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. SLRX currently screens at market cap $4.9M.
Not investment advice. Open the HAL and SLRX stock pages for the full models.
Not investment advice.